Skip to main content
. Author manuscript; available in PMC: 2020 Oct 23.
Published in final edited form as: Vaccine. 2019 Sep 24;37(45):6824–6831. doi: 10.1016/j.vaccine.2019.09.030

Figure 1. Schematic of Ad5 (E1-,E2b-) expressing LASV GPC or NP.

Figure 1.

(A) Schematic of the adenovirus genome with mutations in the E1, E3 and E2b domains. (B) Western blotting of GPC and NP.